Biology of the Nutraceutical L-Citrulline
营养保健品 L-瓜氨酸的生物学
基本信息
- 批准号:RGPIN-2015-04946
- 负责人:
- 金额:$ 2.11万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Discovery Grants Program - Individual
- 财政年份:2020
- 资助国家:加拿大
- 起止时间:2020-01-01 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Biology of the Nutraceutical L-Citrulline
Background: L-citrulline (LC) is an a-amino acid synthesized from L-ornithine and carbamoyl phosphate in the Urea Cycle via ornithine carbamoyltransferase, while it also serves as a by-product of the nitric oxide (NO) synthase (NOS) reaction, which converts L-arginine into LC and NO. Of interest, LC can be purchased over the counter as a dietary supplement. Studies in humans have shown that LC may act as a performance enhancer, however, the biological actions of LC, and the mechanisms by which LC may enhance performance have been relatively understudied. My goal is to delineate the biological actions of LC in skeletal and cardiac muscle.
Hypothesis: I hypothesize that LC enhances metabolism in exercising muscle via increasing peroxisome proliferator-activated receptor gamma coactivator 1a activity, which enhances mitochondrial function.
Methodology: My laboratory will utilize a number of in vitro/in vivo approaches to elucidate the biological actions of LC in skeletal and cardiac muscle. This includes culturing of neonatal rat cardiac myocytes (NRCMs), H9c2 ventricular myocytes, and C2C12 skeletal myotubes. Furthermore, mice will be subjected to a number of procedures (i.e. high fat diet, exercise), to determine whether LC treatment influences mitochondrial function and oxidative metabolism via indirect calorimetry and mRNA/protein expression profiling of muscle/cardiac extracts. Last, we will assess respiration in isolated muscle/heart mitochondria.
Aims: This research proposal will encompass 3 specific aims; (1) to determine the signaling pathways activated in muscle and heart following treatment with LC, (2) to determine whether LC treatment enhances mitochondrial function in the muscle and heart, and (3) to determine the relative importance of LC versus NO formation in NOS-mediated increases in mitochondrial function. In aim 1, we will treat cultured C2C12 myotubes, H9c2 myocytes, and NRCMs with LC and harvest cell extracts to assess mRNA/protein expression profiles. In aim 2, we will isolate mitochondria from both mouse heart and skeletal muscle and determine whether LC treatment enhances respiration. Furthermore, we will use indirect calorimetry to measure O2 consumption in lean and obese mice treated with LC in their drinking water. In aim 3, we will supplement lean and obese endothelial NOS deficient mice with either LC or a NO donor and assess mitochondrial function.
Impact: Our findings will yield insight into the biological actions of LC in muscle and heart. Moreover, the results of this research program should enhance our understanding of the cellular processes that drive mitochondrial respiration. Last, our findings should also provide significant insights into what "claims" should be allowed for manufacturers who market LC as an over-the-counter nutraceutical dietary supplement to augment exercise performance.
营养保健L瓜氨酸的生物学特性
背景:L-瓜氨酸是L-鸟氨酸和氨基甲酰磷酸在尿素循环中通过鸟氨酸氨基甲酰转移酶合成的一种α-氨基酸,同时也是一氧化氮合酶反应的副产物,将L-精氨酸转化为LC和NO。有趣的是,LC可以作为膳食补充剂在柜台上购买。在人体上的研究表明,LC可能是一种性能增强剂,然而,LC的生物学作用以及LC提高性能的机制还相对研究较少。我的目标是描述LC在骨骼肌和心肌中的生物学作用。
假设:我假设LC通过增加过氧化物酶体增殖物激活受体γ辅活化子1a的活性来增强运动肌肉的代谢,从而增强线粒体的功能。
方法:我的实验室将利用一些体外/体内方法来阐明LC在骨骼肌和心肌中的生物学作用。这包括培养新生大鼠心肌细胞(NRCM)、H9c2心室肌细胞和C2C12骨骼肌管。此外,小鼠将接受一系列的程序(即高脂饮食、运动),以确定LC治疗是否影响线粒体功能和氧化代谢,通过间接量热法和肌肉/心脏提取物的mRNA/蛋白质表达谱来确定。最后,我们将评估分离的肌肉/心脏线粒体的呼吸。
目的:本研究计划包括三个具体目标:(1)确定LC治疗后肌肉和心脏中激活的信号通路,(2)确定LC治疗是否增强了肌肉和心脏的线粒体功能,以及(3)确定LC和NO在一氧化氮合酶(NOS)介导的线粒体功能增加中的相对重要性。在目标1中,我们将用LC和采集细胞提取液处理培养的C2C12肌管、H9c2肌细胞和NRCM,以评估mRNA/蛋白质的表达谱。在目标2中,我们将分离小鼠心脏和骨骼肌的线粒体,并确定LC治疗是否增强呼吸。此外,我们将使用间接量热法来测量瘦小和肥胖小鼠在LC处理后的饮用水中的O2消耗。在目标3中,我们将用LC或NO供体补充瘦小和肥胖的内皮一氧化氮合酶缺陷小鼠,并评估线粒体功能。
影响:我们的发现将有助于深入了解LC在肌肉和心脏中的生物学作用。此外,这项研究计划的结果应该会加强我们对驱动线粒体呼吸的细胞过程的理解。最后,我们的发现还应该为那些将LC作为非处方药营养膳食补充剂来增强运动性能的制造商提供重要的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ussher, JohnEdward其他文献
Ussher, JohnEdward的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ussher, JohnEdward', 18)}}的其他基金
Biology of the Nutraceutical L-Citrulline
营养保健品 L-瓜氨酸的生物学
- 批准号:
RGPIN-2015-04946 - 财政年份:2021
- 资助金额:
$ 2.11万 - 项目类别:
Discovery Grants Program - Individual
Biology of the Nutraceutical L-Citrulline
营养保健品 L-瓜氨酸的生物学
- 批准号:
RGPIN-2015-04946 - 财政年份:2019
- 资助金额:
$ 2.11万 - 项目类别:
Discovery Grants Program - Individual
Biology of the Nutraceutical L-Citrulline
营养保健品 L-瓜氨酸的生物学
- 批准号:
RGPIN-2015-04946 - 财政年份:2018
- 资助金额:
$ 2.11万 - 项目类别:
Discovery Grants Program - Individual
Biology of the Nutraceutical L-Citrulline
营养保健品 L-瓜氨酸的生物学
- 批准号:
RGPIN-2015-04946 - 财政年份:2017
- 资助金额:
$ 2.11万 - 项目类别:
Discovery Grants Program - Individual
Biology of the Nutraceutical L-Citrulline
营养保健品 L-瓜氨酸的生物学
- 批准号:
RGPIN-2015-04946 - 财政年份:2016
- 资助金额:
$ 2.11万 - 项目类别:
Discovery Grants Program - Individual
Biology of the Nutraceutical L-Citrulline
营养保健品 L-瓜氨酸的生物学
- 批准号:
RGPIN-2015-04946 - 财政年份:2015
- 资助金额:
$ 2.11万 - 项目类别:
Discovery Grants Program - Individual
相似海外基金
Precision Nutrition for Gut Health: Development of a novel seaweed-containing, gut microbiota targeted nutraceutical
肠道健康的精准营养:开发一种新型的含海藻、针对肠道微生物群的营养保健品
- 批准号:
2886525 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Studentship
Drug-gene-nutraceutical interactions of cannabidiol
大麻二酚的药物-基因-营养药物相互作用
- 批准号:
10366842 - 财政年份:2022
- 资助金额:
$ 2.11万 - 项目类别:
Drug-gene-nutraceutical interactions of cannabidiol
大麻二酚的药物-基因-营养药物相互作用
- 批准号:
10577835 - 财政年份:2022
- 资助金额:
$ 2.11万 - 项目类别:
Softabs-designing sugar-free viscoelastic drug delivery capsules for hydrophobic cannabinoid, nutraceutical, and pharmacological delivery across mucosal membranes
Softabs 设计的无糖粘弹性药物递送胶囊,用于疏水性大麻素、营养保健品和跨粘膜的药物递送
- 批准号:
571220-2021 - 财政年份:2022
- 资助金额:
$ 2.11万 - 项目类别:
Alliance Grants
Plant Protein, Structure Function and Nutraceutical Delivery
植物蛋白、结构功能和营养物质输送
- 批准号:
CRC-2019-00243 - 财政年份:2022
- 资助金额:
$ 2.11万 - 项目类别:
Canada Research Chairs
The development of a commercially scalable extraction process for Aramune™ a novel plant based immunomodulatory polysaccharide with ICURe substantiated commercial application in animal feed, nutraceutical and pharmaceutical markets
Aramune™ 是一种新型植物免疫调节多糖,其商业化规模化提取工艺的开发已在 ICURe 中得到证实,已在动物饲料、营养保健品和药品市场上得到商业应用
- 批准号:
10001310 - 财政年份:2021
- 资助金额:
$ 2.11万 - 项目类别:
Study
Biology of the Nutraceutical L-Citrulline
营养保健品 L-瓜氨酸的生物学
- 批准号:
RGPIN-2015-04946 - 财政年份:2021
- 资助金额:
$ 2.11万 - 项目类别:
Discovery Grants Program - Individual
Plant Protein, Structure Function And Nutraceutical Delivery
植物蛋白、结构功能和营养物质输送
- 批准号:
CRC-2019-00243 - 财政年份:2021
- 资助金额:
$ 2.11万 - 项目类别:
Canada Research Chairs
Characterization and In-Vitro Assessment of Pathogen Binding Performance of Engineered Mannooligosaccharides for Nutraceutical Application
用于营养保健品应用的工程甘露寡糖的病原体结合性能的表征和体外评估
- 批准号:
467199 - 财政年份:2021
- 资助金额:
$ 2.11万 - 项目类别:
Studentship Programs
Plant Protein, Structure Function and Nutraceutical Delivery
植物蛋白、结构功能和营养物质输送
- 批准号:
CRC-2019-00243 - 财政年份:2020
- 资助金额:
$ 2.11万 - 项目类别:
Canada Research Chairs














{{item.name}}会员




